As the major genetic risk factor for AD, apolipoprotein E4 (ApoE4) has been shown to reduce ATP production by regulating the PGC-1α-SIRT3 signaling pathway and triggering subsequent mitochondrial oxidative stress and synapse damage, ultimately causing cognitive impairment [143]. Here, SIRT3 is linked to Alzheimer disease.